Abstract
Identification of the preferred brain substrates of calpain in vivo is not an easy task. The first difficulty is that, given enough time, almost any protein will be degraded when incubated in the presence of calpain and Ca+ in a test tube. A second major problem is the lack of completely specific calpain inhibitors that can effectively block calpain activity in the brain in vivo. Finally, even when the criteria for identification of such substrates are satisfied, one would like to know under which experimental conditions particular substrates are degraded and, if possible, the regional and cellular localization of the degradation. Numerous reports have suggested that spectrin is one of the substrates preferred by calpain, and calpain-mediated spectrin degradation has been widely used as an index of calpain activation in vitro as well as in vivo. The identification of the site in α-spectrin cleaved by calpain led to the preparation of antibodies against the newly exposed C-and N-terminal peptides at the spectrin cleavage site. These antibodies were used to localize calpain-mediated spectrin degradation in brain under a number of experimental conditions, showing that seizure activity, ischemia, and tetanic stimulation produce very selective calpain activation in hippocampus and other brain structures. However, it is now known that this spectrin site is cleaved not only by calpain, but also by other proteases, such as some members of the caspase family.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baudry M., Bundman M. C., Smith E. K., and Lynch G. (1981) Micromolar levels of calcium stimulate proteolytic activity and glutamate receptor binding in rat brain synaptic membranes. Science 212, 937–938.
Siman R., Baudry M., and Lynch G. (1985) Regulation of glutamate receptor binding by the cytoskeletal protein fodrin. Nature 313, 17–23.
Kessler M., Petersen G., Vu H. M., Baudry M., and Lynch G. (1987) Phe-Glu stimulated, chloride-dependent glutamate “binding” represents glutamate sequestration mediated by an exchange system. J. Neurochem. 48, 1191–1200.
Tocco G., Massicotte G., Standley S., Thompson R. F., and Baudry M. (1992) Effect of temperature and calcium on the binding properties of the AMPA receptor in frozen rat brain sections. Eur. J. Neurosci. 4, 1093–1103.
Bi X., Standley S., and Baudry M. (1998) Post-translational regulation of ionotropic glutamate receptors and synaptic plasticity. Int. Rev. Neurobiol. 42, 227–284.
Musleh W., Bi X., Tocco G., Yaghoubi S., and Baudry M. (1997) Glycine-induced long-term potentiation is associated with structural and functional modifications of AMPA receptors. Proc. Natl. Acad. Sci. U.S.A. 94, 9451–9456.
Massicotte G., Kessler M., Lynch G., and Baudry M. (1990) N-Methyl-D-aspartate and quisqualate/AMPA receptors: Differential regulation by phospholi-pase C treatment. Mol. Pharmacol. 32, 278–85.
Massicotte G. and Baudry M., (1990) Modulation of AMPA/quisqualate receptors by phospholipase A2 treatment. Neurosci. Lett. 118, 245–248.
Massicotte G., Bernard J., and Baudry M. (1992) Postnatal changes in AMPA receptor regulation by phospholipase A2 treatment of synaptic membranes: Temporally differential effects on agonist and antagonist binding. Dev. Brain Res. 66, 203–208.
Stoppini L., Buchs P., and Muller D. (1991) A simple method for organotypic culture of nervous tissue. J. Neurosci. Methods. 37, 173–182.
Hennegriff M., Arai A., Kessler M., Vanderklish P., Mutneja M. S., Rogers G., Neve R. L., and Lynch G. (1997) Stable expression of recombinant AMPA receptor subunits: binding affinities and effects of allosteric modulators. J. Neurochem. 68, 2424–2434.
Bi X., Chang V., Molnar E., McIlhinney J., and Baudry M. (1996) The C-terminal domain of GluR1 subunits is a target for calpain-mediated proteolysis. Neuroscience. 73, 903–906.
Bi X., Chen J., Dang S., Wenthold R. J., Tocco G., and Baudry M. (1997)Characterization of calpain-mediated proteolysis of GluR1 subunits of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptors in rat brain. J. Neurochem. 68, 1484–1493.
Bi X., Rong Y., Chen J., Dang S., Wang Z., and Baudry M., (1998) Calpain-mediated regulation of NMDA receptor structure and function. Brain Res. 790, 245–253.
Bi R., Bi X., and Baudry M. (1998) Phosphorylation regulates calpain-mediated truncation of glutamate ionotropic receptors. Brain Res. 797, 154–158.
Bi X., Tocco G. and Baudry M. (1994) Calpain-mediated regulation of AMPA receptors in adult rat brains. NeuroReport 6, 61–64.
Marvizon J. C. and Baudry M. (1994) [3H]dizocilpine association kinetics distinguish stimulatory and inhibitory polyamine sites of N-methyl-D-aspartate receptors. J. Neurochem. 63, 963–971.
Gellerman D., Bi X., and Baudry M. (1997) NMDA receptor-mediated regulation of AMPA receptor properties in organotypic culture. J. Neurochem. 69, 131–136.
Bi X., Chen J., and Baudry M. (1998) Calpain-mediated proteolysis of GluR1 subunits in organotypic hippocampal cultures following kainic acid treatment. Brain Res. 781, 355–357.
Bruce A. J., Sakhi S., Schreiber S. S., and Baudry M. (1995) Development of kainic acid and N-methyl-D-aspartic acid toxicity in organotypic hippocampal cultures. Exp. Neurol. 132, 209–219.
Bi X., Chang V., Siman R., Tocco G., and Baudry M. (1996) Regional distribution and time-course of calpain activation following kainate induce seizure activity in adult rat brain. Brain Res. 726, 98–108.
Bi X., Chen J., and Baudry M. (1997) Developmental changes in calpain activity, GluR1 receptors and in the effect of kainic acid treatment in rat brain. Neuroscience. 81, 1123–1135.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Bi, X., Bi, R., Baudry, M. (2000). Calpain-Mediated Truncation of Glutamate Ionotropic Receptors. In: Elce, J.S. (eds) Calpain Methods and Protocols. Methods in Molecular Biology™, vol 144. Humana Press. https://doi.org/10.1385/1-59259-050-0:203
Download citation
DOI: https://doi.org/10.1385/1-59259-050-0:203
Publisher Name: Humana Press
Print ISBN: 978-0-89603-632-1
Online ISBN: 978-1-59259-050-6
eBook Packages: Springer Protocols